Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-11-6
pubmed:abstractText
Schizophrenia may result from altered gene expression leading to abnormal neurodevelopment. In a search for genes with altered expression in schizophrenia, our previous work on human frontal cerebral cortex found the mRNA of Nogo, a myelin-associated protein which inhibits the outgrowth of neurites and nerve terminals, to be overexpressed in schizophrenia. Because those earlier results did not examine tissues for the separate Nogo A, B and C isoforms from age- and sex-matched individuals, we repeated the study for all three isoforms, using a new set of tissues from matched individuals, and using the more accurate method of quantitative real-time PCR (polymerase chain reaction). We found Nogo C to be overexpressed by 26% in the schizophrenia tissues, which is in accordance with our earlier results. The expression of Nogo B was statistically significantly reduced by 17% in the frontal cortices from individuals who had been diagnosed as having had severe depression. Furthermore, we show that there is a direct correlation between the expression of Nogo A and C and the presence of alleles with a CAA insert, irrespective of disease status. While upregulation of Nogo C expression may play a role in schizophrenia, altered Nogo B may contribute to the clinical condition of depression. Nogo A showed a statistically non-significant increase in expression in schizophrenia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0006-8993
pubmed:author
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
1120
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
161-71
pubmed:meshHeading
pubmed-meshheading:17022955-3' Untranslated Regions, pubmed-meshheading:17022955-Adult, pubmed-meshheading:17022955-Bipolar Disorder, pubmed-meshheading:17022955-DNA, Complementary, pubmed-meshheading:17022955-Depression, pubmed-meshheading:17022955-Female, pubmed-meshheading:17022955-Frontal Lobe, pubmed-meshheading:17022955-Gene Expression, pubmed-meshheading:17022955-Gene Frequency, pubmed-meshheading:17022955-Genetic Predisposition to Disease, pubmed-meshheading:17022955-Humans, pubmed-meshheading:17022955-Male, pubmed-meshheading:17022955-Middle Aged, pubmed-meshheading:17022955-Myelin Proteins, pubmed-meshheading:17022955-Polymorphism, Genetic, pubmed-meshheading:17022955-Postmortem Changes, pubmed-meshheading:17022955-Protein Isoforms, pubmed-meshheading:17022955-RNA, Messenger, pubmed-meshheading:17022955-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:17022955-Schizophrenia
pubmed:year
2006
pubmed:articleTitle
Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3'-UTR.
pubmed:affiliation
Department of Pharmacology, Medical Sciences Building 4344, University of Toronto, 1 King's College Circle, Toronto, Canada M5S 1A8.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural